Submit Your Article CMED MEACR meeting
An official publication of the Middle-Eastern Association for Cancer Research
Clinical Cancer Investigation Journal
ARTICLE
Year: 2014   |   Volume: 3   |   Issue: 5   |   Page: 363-372     View issue

A systematic review of management of neuroendocrine tumors: An experience from a tertiary care centre from India


Rakesh Kapoor, Tapesh Bhattacharyya, Rajesh Gupta, B Mittal, Naveen Kalra
Abstract

Neuroendocrine tumors (NETs) encompass a heterogeneous group of tumors demonstrating varied clinical behavior. The field has recently witnessed several important developments stemming from improvements in the histopathological classification schemes, advanced imaging techniques, and a deeper understanding of the molecular mechanisms underlying tumor progression. These tumors have indolent clinical courses, with long survival rates even for the patients with metastatic disease. The mainstay of treatment is surgery. Somatostatin analogs play a key role in controlling the symptoms; however, they are seldom associated with tumor regression. Traditional cytotoxic chemotherapies have a very limited role in well differentiated NETs, but platinum based chemotherapy is highly effective in neuroendocrine carcinomas. Recently, the biological targeted agents have shown promise in patients with metastatic disease. Evolving modalities like peptide receptor targeted therapies and radioembolization have opened up new avenues in refractory and advanced disease.

Cite this article
Vancouver
Kapoor R, Bhattacharyya T, Gupta R, Mittal B, Kalra N. A systematic review of management of neuroendocrine tumors: An experience from a tertiary care centre from India. Clin Cancer Investig J. 2014;3(5):363-72. https://doi.org/10.4103/2278-0513.138052
APA
Kapoor, R., Bhattacharyya, T., Gupta, R., Mittal, B., & Kalra, N. (2014). A systematic review of management of neuroendocrine tumors: An experience from a tertiary care centre from India. Clinical Cancer Investigation Journal, 3(5), 363-372. https://doi.org/10.4103/2278-0513.138052

Sitemap | What's New | Feedback | Copyright and Disclaimer | Privacy Notice
© Clinical Cancer Investigation Journal | Published by Polaris Publication
Online since 01 December, 2011
Editorial and Ethics Policies
Creative Commons  Open Access Journal View mobile site 
ISSN: Print -2278-1668, Online - 2278-0513